Phage and Antibiotic Synergy
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Bacteriophages".
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 11349
Special Issue Editor
Interests: inhaled phage therapeutics; phage therapy; phage formulation; respiratory infections
Special Issue Information
Dear Colleagues,
With the global misuse of antibiotics, the rapid emergence of multidrug-resistant (and even pandrug-resistant) bacteria is occurring worldwide. More bacterial infections are becoming difficult to treat, and are often associated with high morbidity, mortality and financial burden. Bacteriophages (or phages) are natural predators of bacteria that have the potential to revolutionize the treatment of multidrug-resistant bacterial infections. Over the past decade, phage therapy has been reconsidered as an alternative and/or adjunct to antibiotic therapy in Western countries. More recently, phage and antibiotic synergy has attracted attention due to marked improvement in efficacy and a reduced risk of developing phage- and antibiotic-resistant isolates. Numerous in vitro and in vivo studies have been conducted to better understand the synergy and underlying mechanisms, as well as to demonstrate efficacy against planktonic cells and biofilms.
Phage and antibiotic synergy—from basic science to in vivo studies—is a rapidly evolving field and this Special Issue of Antibiotics seeks to bring together manuscripts to enhance our understanding of phage and antibiotic synergy. We are gathering contributions in the form of original research articles, short communications, and critical narrative or systematic reviews covering all aspects of phage and antibiotic synergy, including, but not limited to, systemic identification of synergistic pair of phage and antibiotic, formulation of the pair, the mechanisms underlying synergy, and in vitro and in vivo efficacy and safety studies.
Dr. Rachel Yoon Chang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bacteriophage (phage)
- Phage therapy
- Phage and antibiotic synergy (PAS)
- Antimicrobial resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
